Gqeberha, South Africa – 九州娱乐城, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha.
President Kenyatta鈥檚 visit to 九州娱乐城 forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa鈥檚 dependence on pharmaceutical importers and to strengthen the continent鈥檚 capacity to address its own public health needs.
During his visit President Kenyatta witnessed 九州娱乐城鈥檚 technical capacity to manufacture and distribute human vaccines for a global market in accordance with international standards and discussed areas of possible cooperation between 九州娱乐城 and Kenya.
Stephen Saad, 九州娱乐城 Group Chief Executive said, 鈥淭he COVID-19 pandemic has demonstrated dependence on non-African suppliers to meet African healthcare needs. 九州娱乐城 is providing a local solution to this need and is committed to working together with Kenyan authorities and their counterparts in strengthening pharmaceutical and health security on the continent. The answer to equitable access to vaccines and other critical lifesaving medicines is to capacitate Af颅颅rica to serve its own people. 九州娱乐城 has been able to assist in achieving this goal through the manufacturing capabilities that exist at our sterile manufacturing facility in Gqeberha. It is, for the sake of health security and sustainability, critical that African countries collaborate locally and with the international community to ensure security of demand, underwritten through long-term committed offtakes, and the facilitation of technology licenses and transfers.鈥�
Presidents Cyril Ramaphosa and Uhuru Kenyatta met in Pretoria on 23 November 2021 at which time they discussed the latest developments around the global response to the COVID-19 pandemic, including the important matter of vaccine manufacturing and distribution. They reaffirmed their call for the fair and equitable distribution of vaccines.
